Global Cell-free Tumor DNA Detection Production, Demand and Key Producers, 2022-2028
Cell-free tumor DNA (circulating tumor DNA, ctDNA) testing, the so-called 'liquid biopsy'. ctDNA refers to the DNA released by tumor cells into the blood circulatory system, which contains information on tumor-derived mutations and gene variations. ctDNA is a tumor marker with broad application prospects, high sensitivity and high specificity, and is suitable for a variety of tumors, providing an opportunity for non-invasive sampling of tumors.
This report studies the global Cell-free Tumor DNA Detection demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell-free Tumor DNA Detection, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell-free Tumor DNA Detection that contribute to its increasing demand across many markets.
The global Cell-free Tumor DNA Detection market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Cell-free Tumor DNA Detection total market, 2017-2028, (USD Million)
Global Cell-free Tumor DNA Detection total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Cell-free Tumor DNA Detection total market, key domestic companies and share, (USD Million)
Global Cell-free Tumor DNA Detection revenue by player and market share 2017-2022, (USD Million)
Global Cell-free Tumor DNA Detection total market by Type, CAGR, 2017-2028, (USD Million)
Global Cell-free Tumor DNA Detection total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Cell-free Tumor DNA Detection market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen, NeoGenomics Laboratories Inc., Menarini Silicon Biosystems and Illumina Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell-free Tumor DNA Detection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Cell-free Tumor DNA Detection Market, By Region:
1. How big is the global Cell-free Tumor DNA Detection market?
2. What is the demand of the global Cell-free Tumor DNA Detection market?
3. What is the year over year growth of the global Cell-free Tumor DNA Detection market?
4. What is the total value of the global Cell-free Tumor DNA Detection market?
5. Who are the major players in the global Cell-free Tumor DNA Detection market?
6. What are the growth factors driving the market demand?
This report studies the global Cell-free Tumor DNA Detection demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell-free Tumor DNA Detection, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell-free Tumor DNA Detection that contribute to its increasing demand across many markets.
The global Cell-free Tumor DNA Detection market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Cell-free Tumor DNA Detection total market, 2017-2028, (USD Million)
Global Cell-free Tumor DNA Detection total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Cell-free Tumor DNA Detection total market, key domestic companies and share, (USD Million)
Global Cell-free Tumor DNA Detection revenue by player and market share 2017-2022, (USD Million)
Global Cell-free Tumor DNA Detection total market by Type, CAGR, 2017-2028, (USD Million)
Global Cell-free Tumor DNA Detection total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Cell-free Tumor DNA Detection market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen, NeoGenomics Laboratories Inc., Menarini Silicon Biosystems and Illumina Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell-free Tumor DNA Detection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Cell-free Tumor DNA Detection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Droplet Digital Polymerase Chain Reaction
- Tagged-Amplicon Deep Sequencing
- Others
- Breast Cancer
- Stomach Cancer
- Liver Cancer
- Other
- Biocept Inc.
- Bio-Rad Laboratories Inc.
- Fluxion Biosciences Inc.
- F. Hoffmann-La Roche AG
- Sysmex Europe SE
- Qiagen
- NeoGenomics Laboratories Inc.
- Menarini Silicon Biosystems
- Illumina Inc.
- Guardant Health Inc.
- Shanghai Biotecan Medical Diagnostics Co.,Ltd.
1. How big is the global Cell-free Tumor DNA Detection market?
2. What is the demand of the global Cell-free Tumor DNA Detection market?
3. What is the year over year growth of the global Cell-free Tumor DNA Detection market?
4. What is the total value of the global Cell-free Tumor DNA Detection market?
5. Who are the major players in the global Cell-free Tumor DNA Detection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cell-free Tumor DNA Detection Introduction
1.2 World Cell-free Tumor DNA Detection Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Cell-free Tumor DNA Detection Total Market by Region
1.3.1 World Cell-free Tumor DNA Detection Market Size by Region (2017-2028)
1.3.2 United States Cell-free Tumor DNA Detection Market Size (2017-2028)
1.3.3 China Cell-free Tumor DNA Detection Market Size (2017-2028)
1.3.4 Europe Cell-free Tumor DNA Detection Market Size (2017-2028)
1.3.5 Japan Cell-free Tumor DNA Detection Market Size (2017-2028)
1.3.6 South Korea Cell-free Tumor DNA Detection Market Size (2017-2028)
1.3.7 ASEAN Cell-free Tumor DNA Detection Market Size (2017-2028)
1.3.8 India Cell-free Tumor DNA Detection Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell-free Tumor DNA Detection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell-free Tumor DNA Detection Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD CELL-FREE TUMOR DNA DETECTION COMPANIES COMPETITIVE ANALYSIS
2.1 World Cell-free Tumor DNA Detection Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Cell-free Tumor DNA Detection Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Cell-free Tumor DNA Detection in 2021
2.2.3 Global Concentration Ratios (CR8) for Cell-free Tumor DNA Detection in 2021
2.3 Cell-free Tumor DNA Detection Company Evaluation Quadrant
2.4 Cell-free Tumor DNA Detection Market: Overall Company Footprint Analysis
2.4.1 Cell-free Tumor DNA Detection Market: Region Footprint
2.4.2 Cell-free Tumor DNA Detection Market: Company Product Type Footprint
2.4.3 Cell-free Tumor DNA Detection Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Cell-free Tumor DNA Detection Market Comparison
3.1.1 United States VS China: Cell-free Tumor DNA Detection Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Cell-free Tumor DNA Detection Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Cell-free Tumor DNA Detection Major Players and Market Share, 2017-2022
3.2.1 Major Players of Cell-free Tumor DNA Detection in United States, Headquarters (States, Country)
3.2.2 United States Cell-free Tumor DNA Detection Revenue by Domestic Player, (2017-2022)
3.3 China Cell-free Tumor DNA Detection Major Players and Market Share, 2017-2022
3.3.1 Major Players of Cell-free Tumor DNA Detection in China, Headquarters (Province, Country)
3.3.2 China Cell-free Tumor DNA Detection Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Cell-free Tumor DNA Detection Major Players and Market Share, 2017-2022
3.4.1 Major Players of Cell-free Tumor DNA Detection in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Cell-free Tumor DNA Detection Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Cell-free Tumor DNA Detection Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Droplet Digital Polymerase Chain Reaction
4.2.2 Tagged-Amplicon Deep Sequencing
4.2.3 Others
4.3 Market Segment by Type
4.3.1 World Cell-free Tumor DNA Detection Market Size by Type (2017-2022)
4.3.2 World Cell-free Tumor DNA Detection Market Size by Type (2023-2028)
4.3.3 World Cell-free Tumor DNA Detection Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Cell-free Tumor DNA Detection Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Breast Cancer
5.2.2 Stomach Cancer
5.2.3 Liver Cancer
5.2.4 Other
5.2.5 Other
5.3 Market Segment by Application
5.3.1 World Cell-free Tumor DNA Detection Market Size by Application (2017-2022)
5.3.2 World Cell-free Tumor DNA Detection Market Size by Application (2023-2028)
5.3.3 World Cell-free Tumor DNA Detection Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Biocept Inc.
6.1.1 Biocept Inc. Details
6.1.2 Biocept Inc. Major Business
6.1.3 Biocept Inc. Cell-free Tumor DNA Detection Product and Services
6.1.4 Biocept Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Biocept Inc. Recent Developments/Updates
6.1.6 Biocept Inc. Competitive Strengths & Weaknesses
6.2 Bio-Rad Laboratories Inc.
6.2.1 Bio-Rad Laboratories Inc. Details
6.2.2 Bio-Rad Laboratories Inc. Major Business
6.2.3 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product and Services
6.2.4 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Bio-Rad Laboratories Inc. Recent Developments/Updates
6.2.6 Bio-Rad Laboratories Inc. Competitive Strengths & Weaknesses
6.3 Fluxion Biosciences Inc.
6.3.1 Fluxion Biosciences Inc. Details
6.3.2 Fluxion Biosciences Inc. Major Business
6.3.3 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product and Services
6.3.4 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Fluxion Biosciences Inc. Recent Developments/Updates
6.3.6 Fluxion Biosciences Inc. Competitive Strengths & Weaknesses
6.4 F. Hoffmann-La Roche AG
6.4.1 F. Hoffmann-La Roche AG Details
6.4.2 F. Hoffmann-La Roche AG Major Business
6.4.3 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product and Services
6.4.4 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 F. Hoffmann-La Roche AG Recent Developments/Updates
6.4.6 F. Hoffmann-La Roche AG Competitive Strengths & Weaknesses
6.5 Sysmex Europe SE
6.5.1 Sysmex Europe SE Details
6.5.2 Sysmex Europe SE Major Business
6.5.3 Sysmex Europe SE Cell-free Tumor DNA Detection Product and Services
6.5.4 Sysmex Europe SE Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Sysmex Europe SE Recent Developments/Updates
6.5.6 Sysmex Europe SE Competitive Strengths & Weaknesses
6.6 Qiagen
6.6.1 Qiagen Details
6.6.2 Qiagen Major Business
6.6.3 Qiagen Cell-free Tumor DNA Detection Product and Services
6.6.4 Qiagen Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Qiagen Recent Developments/Updates
6.6.6 Qiagen Competitive Strengths & Weaknesses
6.7 NeoGenomics Laboratories Inc.
6.7.1 NeoGenomics Laboratories Inc. Details
6.7.2 NeoGenomics Laboratories Inc. Major Business
6.7.3 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product and Services
6.7.4 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 NeoGenomics Laboratories Inc. Recent Developments/Updates
6.7.6 NeoGenomics Laboratories Inc. Competitive Strengths & Weaknesses
6.8 Menarini Silicon Biosystems
6.8.1 Menarini Silicon Biosystems Details
6.8.2 Menarini Silicon Biosystems Major Business
6.8.3 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product and Services
6.8.4 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Menarini Silicon Biosystems Recent Developments/Updates
6.8.6 Menarini Silicon Biosystems Competitive Strengths & Weaknesses
6.9 Illumina Inc.
6.9.1 Illumina Inc. Details
6.9.2 Illumina Inc. Major Business
6.9.3 Illumina Inc. Cell-free Tumor DNA Detection Product and Services
6.9.4 Illumina Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Illumina Inc. Recent Developments/Updates
6.9.6 Illumina Inc. Competitive Strengths & Weaknesses
6.10 Guardant Health Inc.
6.10.1 Guardant Health Inc. Details
6.10.2 Guardant Health Inc. Major Business
6.10.3 Guardant Health Inc. Cell-free Tumor DNA Detection Product and Services
6.10.4 Guardant Health Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Guardant Health Inc. Recent Developments/Updates
6.10.6 Guardant Health Inc. Competitive Strengths & Weaknesses
6.11 Shanghai Biotecan Medical Diagnostics Co.,Ltd.
6.11.1 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Details
6.11.2 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Major Business
6.11.3 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product and Services
6.11.4 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Developments/Updates
6.11.6 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Cell-free Tumor DNA Detection and Key Manufacturers
7.2 Cell-free Tumor DNA Detection Manufacturing Costs
7.3 Cell-free Tumor DNA Detection Production Process
7.4 Cell-free Tumor DNA Detection Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Cell-free Tumor DNA Detection Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Cell-free Tumor DNA Detection Typical Distributors
8.3 Cell-free Tumor DNA Detection Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cell-free Tumor DNA Detection Introduction
1.2 World Cell-free Tumor DNA Detection Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Cell-free Tumor DNA Detection Total Market by Region
1.3.1 World Cell-free Tumor DNA Detection Market Size by Region (2017-2028)
1.3.2 United States Cell-free Tumor DNA Detection Market Size (2017-2028)
1.3.3 China Cell-free Tumor DNA Detection Market Size (2017-2028)
1.3.4 Europe Cell-free Tumor DNA Detection Market Size (2017-2028)
1.3.5 Japan Cell-free Tumor DNA Detection Market Size (2017-2028)
1.3.6 South Korea Cell-free Tumor DNA Detection Market Size (2017-2028)
1.3.7 ASEAN Cell-free Tumor DNA Detection Market Size (2017-2028)
1.3.8 India Cell-free Tumor DNA Detection Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell-free Tumor DNA Detection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell-free Tumor DNA Detection Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD CELL-FREE TUMOR DNA DETECTION COMPANIES COMPETITIVE ANALYSIS
2.1 World Cell-free Tumor DNA Detection Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Cell-free Tumor DNA Detection Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Cell-free Tumor DNA Detection in 2021
2.2.3 Global Concentration Ratios (CR8) for Cell-free Tumor DNA Detection in 2021
2.3 Cell-free Tumor DNA Detection Company Evaluation Quadrant
2.4 Cell-free Tumor DNA Detection Market: Overall Company Footprint Analysis
2.4.1 Cell-free Tumor DNA Detection Market: Region Footprint
2.4.2 Cell-free Tumor DNA Detection Market: Company Product Type Footprint
2.4.3 Cell-free Tumor DNA Detection Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Cell-free Tumor DNA Detection Market Comparison
3.1.1 United States VS China: Cell-free Tumor DNA Detection Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Cell-free Tumor DNA Detection Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Cell-free Tumor DNA Detection Major Players and Market Share, 2017-2022
3.2.1 Major Players of Cell-free Tumor DNA Detection in United States, Headquarters (States, Country)
3.2.2 United States Cell-free Tumor DNA Detection Revenue by Domestic Player, (2017-2022)
3.3 China Cell-free Tumor DNA Detection Major Players and Market Share, 2017-2022
3.3.1 Major Players of Cell-free Tumor DNA Detection in China, Headquarters (Province, Country)
3.3.2 China Cell-free Tumor DNA Detection Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Cell-free Tumor DNA Detection Major Players and Market Share, 2017-2022
3.4.1 Major Players of Cell-free Tumor DNA Detection in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Cell-free Tumor DNA Detection Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Cell-free Tumor DNA Detection Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Droplet Digital Polymerase Chain Reaction
4.2.2 Tagged-Amplicon Deep Sequencing
4.2.3 Others
4.3 Market Segment by Type
4.3.1 World Cell-free Tumor DNA Detection Market Size by Type (2017-2022)
4.3.2 World Cell-free Tumor DNA Detection Market Size by Type (2023-2028)
4.3.3 World Cell-free Tumor DNA Detection Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Cell-free Tumor DNA Detection Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Breast Cancer
5.2.2 Stomach Cancer
5.2.3 Liver Cancer
5.2.4 Other
5.2.5 Other
5.3 Market Segment by Application
5.3.1 World Cell-free Tumor DNA Detection Market Size by Application (2017-2022)
5.3.2 World Cell-free Tumor DNA Detection Market Size by Application (2023-2028)
5.3.3 World Cell-free Tumor DNA Detection Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Biocept Inc.
6.1.1 Biocept Inc. Details
6.1.2 Biocept Inc. Major Business
6.1.3 Biocept Inc. Cell-free Tumor DNA Detection Product and Services
6.1.4 Biocept Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Biocept Inc. Recent Developments/Updates
6.1.6 Biocept Inc. Competitive Strengths & Weaknesses
6.2 Bio-Rad Laboratories Inc.
6.2.1 Bio-Rad Laboratories Inc. Details
6.2.2 Bio-Rad Laboratories Inc. Major Business
6.2.3 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product and Services
6.2.4 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Bio-Rad Laboratories Inc. Recent Developments/Updates
6.2.6 Bio-Rad Laboratories Inc. Competitive Strengths & Weaknesses
6.3 Fluxion Biosciences Inc.
6.3.1 Fluxion Biosciences Inc. Details
6.3.2 Fluxion Biosciences Inc. Major Business
6.3.3 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product and Services
6.3.4 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Fluxion Biosciences Inc. Recent Developments/Updates
6.3.6 Fluxion Biosciences Inc. Competitive Strengths & Weaknesses
6.4 F. Hoffmann-La Roche AG
6.4.1 F. Hoffmann-La Roche AG Details
6.4.2 F. Hoffmann-La Roche AG Major Business
6.4.3 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product and Services
6.4.4 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 F. Hoffmann-La Roche AG Recent Developments/Updates
6.4.6 F. Hoffmann-La Roche AG Competitive Strengths & Weaknesses
6.5 Sysmex Europe SE
6.5.1 Sysmex Europe SE Details
6.5.2 Sysmex Europe SE Major Business
6.5.3 Sysmex Europe SE Cell-free Tumor DNA Detection Product and Services
6.5.4 Sysmex Europe SE Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Sysmex Europe SE Recent Developments/Updates
6.5.6 Sysmex Europe SE Competitive Strengths & Weaknesses
6.6 Qiagen
6.6.1 Qiagen Details
6.6.2 Qiagen Major Business
6.6.3 Qiagen Cell-free Tumor DNA Detection Product and Services
6.6.4 Qiagen Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Qiagen Recent Developments/Updates
6.6.6 Qiagen Competitive Strengths & Weaknesses
6.7 NeoGenomics Laboratories Inc.
6.7.1 NeoGenomics Laboratories Inc. Details
6.7.2 NeoGenomics Laboratories Inc. Major Business
6.7.3 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product and Services
6.7.4 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 NeoGenomics Laboratories Inc. Recent Developments/Updates
6.7.6 NeoGenomics Laboratories Inc. Competitive Strengths & Weaknesses
6.8 Menarini Silicon Biosystems
6.8.1 Menarini Silicon Biosystems Details
6.8.2 Menarini Silicon Biosystems Major Business
6.8.3 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product and Services
6.8.4 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Menarini Silicon Biosystems Recent Developments/Updates
6.8.6 Menarini Silicon Biosystems Competitive Strengths & Weaknesses
6.9 Illumina Inc.
6.9.1 Illumina Inc. Details
6.9.2 Illumina Inc. Major Business
6.9.3 Illumina Inc. Cell-free Tumor DNA Detection Product and Services
6.9.4 Illumina Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Illumina Inc. Recent Developments/Updates
6.9.6 Illumina Inc. Competitive Strengths & Weaknesses
6.10 Guardant Health Inc.
6.10.1 Guardant Health Inc. Details
6.10.2 Guardant Health Inc. Major Business
6.10.3 Guardant Health Inc. Cell-free Tumor DNA Detection Product and Services
6.10.4 Guardant Health Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Guardant Health Inc. Recent Developments/Updates
6.10.6 Guardant Health Inc. Competitive Strengths & Weaknesses
6.11 Shanghai Biotecan Medical Diagnostics Co.,Ltd.
6.11.1 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Details
6.11.2 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Major Business
6.11.3 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product and Services
6.11.4 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Developments/Updates
6.11.6 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Cell-free Tumor DNA Detection and Key Manufacturers
7.2 Cell-free Tumor DNA Detection Manufacturing Costs
7.3 Cell-free Tumor DNA Detection Production Process
7.4 Cell-free Tumor DNA Detection Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Cell-free Tumor DNA Detection Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Cell-free Tumor DNA Detection Typical Distributors
8.3 Cell-free Tumor DNA Detection Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cell-free Tumor DNA Detection Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Cell-free Tumor DNA Detection Market Size by Region (2017-2022) & (USD Million)
Table 3. World Cell-free Tumor DNA Detection Market Size by Region (2023-2028) & (USD Million)
Table 4. World Cell-free Tumor DNA Detection Market Size Market Share by Region (2017-2022)
Table 5. World Cell-free Tumor DNA Detection Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Cell-free Tumor DNA Detection Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Cell-free Tumor DNA Detection Players in 2021
Table 9. World Cell-free Tumor DNA Detection Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Cell-free Tumor DNA Detection Company Evaluation Quadrant
Table 11. Head Office of Key Cell-free Tumor DNA Detection Player
Table 12. Cell-free Tumor DNA Detection Market: Company Product Type Footprint
Table 13. Cell-free Tumor DNA Detection Market: Company Product Application Footprint
Table 14. Cell-free Tumor DNA Detection Mergers & Acquisitions Activity
Table 15. United States VS China Cell-free Tumor DNA Detection Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Cell-free Tumor DNA Detection in United States, Headquarters (States, Country)
Table 17. United States Cell-free Tumor DNA Detection Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Cell-free Tumor DNA Detection Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Cell-free Tumor DNA Detection in China, Company Headquarters (Province, Country)
Table 20. China Cell-free Tumor DNA Detection Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Cell-free Tumor DNA Detection Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Cell-free Tumor DNA Detection in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Cell-free Tumor DNA Detection Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Cell-free Tumor DNA Detection Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Cell-free Tumor DNA Detection Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Cell-free Tumor DNA Detection Revenue by Type (2017-2022) & (USD Million)
Table 27. World Cell-free Tumor DNA Detection Revenue by Type (2023-2028) & (USD Million)
Table 28. World Cell-free Tumor DNA Detection Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Cell-free Tumor DNA Detection Revenue by Application (2017-2022) & (USD Million)
Table 30. World Cell-free Tumor DNA Detection Revenue by Application (2023-2028) & (USD Million)
Table 31. Biocept Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Biocept Inc. Major Business
Table 33. Biocept Inc. Cell-free Tumor DNA Detection Product and Services
Table 34. Biocept Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Biocept Inc. Recent Developments/Updates
Table 36. Biocept Inc. Competitive Strengths & Weaknesses
Table 37. Bio-Rad Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 38. Bio-Rad Laboratories Inc. Major Business
Table 39. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product and Services
Table 40. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Bio-Rad Laboratories Inc. Recent Developments/Updates
Table 42. Bio-Rad Laboratories Inc. Competitive Strengths & Weaknesses
Table 43. Fluxion Biosciences Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Fluxion Biosciences Inc. Major Business
Table 45. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product and Services
Table 46. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Fluxion Biosciences Inc. Recent Developments/Updates
Table 48. Fluxion Biosciences Inc. Competitive Strengths & Weaknesses
Table 49. F. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table 50. F. Hoffmann-La Roche AG Major Business
Table 51. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product and Services
Table 52. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. F. Hoffmann-La Roche AG Recent Developments/Updates
Table 54. F. Hoffmann-La Roche AG Competitive Strengths & Weaknesses
Table 55. Sysmex Europe SE Basic Information, Manufacturing Base and Competitors
Table 56. Sysmex Europe SE Major Business
Table 57. Sysmex Europe SE Cell-free Tumor DNA Detection Product and Services
Table 58. Sysmex Europe SE Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Sysmex Europe SE Recent Developments/Updates
Table 60. Sysmex Europe SE Competitive Strengths & Weaknesses
Table 61. Qiagen Basic Information, Manufacturing Base and Competitors
Table 62. Qiagen Major Business
Table 63. Qiagen Cell-free Tumor DNA Detection Product and Services
Table 64. Qiagen Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Qiagen Recent Developments/Updates
Table 66. Qiagen Competitive Strengths & Weaknesses
Table 67. NeoGenomics Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 68. NeoGenomics Laboratories Inc. Major Business
Table 69. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product and Services
Table 70. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. NeoGenomics Laboratories Inc. Recent Developments/Updates
Table 72. NeoGenomics Laboratories Inc. Competitive Strengths & Weaknesses
Table 73. Menarini Silicon Biosystems Basic Information, Manufacturing Base and Competitors
Table 74. Menarini Silicon Biosystems Major Business
Table 75. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product and Services
Table 76. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Menarini Silicon Biosystems Recent Developments/Updates
Table 78. Menarini Silicon Biosystems Competitive Strengths & Weaknesses
Table 79. Illumina Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Illumina Inc. Major Business
Table 81. Illumina Inc. Cell-free Tumor DNA Detection Product and Services
Table 82. Illumina Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Illumina Inc. Recent Developments/Updates
Table 84. Illumina Inc. Competitive Strengths & Weaknesses
Table 85. Guardant Health Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Guardant Health Inc. Major Business
Table 87. Guardant Health Inc. Cell-free Tumor DNA Detection Product and Services
Table 88. Guardant Health Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Guardant Health Inc. Recent Developments/Updates
Table 90. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 91. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Major Business
Table 92. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product and Services
Table 93. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 94. Cell-free Tumor DNA Detection Raw Material
Table 95. Key Manufacturers of Cell-free Tumor DNA Detection Raw Materials
Table 96. Cell-free Tumor DNA Detection Typical Distributors
Table 97. Cell-free Tumor DNA Detection Typical Customers
Table 1. World Cell-free Tumor DNA Detection Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Cell-free Tumor DNA Detection Market Size by Region (2017-2022) & (USD Million)
Table 3. World Cell-free Tumor DNA Detection Market Size by Region (2023-2028) & (USD Million)
Table 4. World Cell-free Tumor DNA Detection Market Size Market Share by Region (2017-2022)
Table 5. World Cell-free Tumor DNA Detection Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Cell-free Tumor DNA Detection Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Cell-free Tumor DNA Detection Players in 2021
Table 9. World Cell-free Tumor DNA Detection Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Cell-free Tumor DNA Detection Company Evaluation Quadrant
Table 11. Head Office of Key Cell-free Tumor DNA Detection Player
Table 12. Cell-free Tumor DNA Detection Market: Company Product Type Footprint
Table 13. Cell-free Tumor DNA Detection Market: Company Product Application Footprint
Table 14. Cell-free Tumor DNA Detection Mergers & Acquisitions Activity
Table 15. United States VS China Cell-free Tumor DNA Detection Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Cell-free Tumor DNA Detection in United States, Headquarters (States, Country)
Table 17. United States Cell-free Tumor DNA Detection Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Cell-free Tumor DNA Detection Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Cell-free Tumor DNA Detection in China, Company Headquarters (Province, Country)
Table 20. China Cell-free Tumor DNA Detection Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Cell-free Tumor DNA Detection Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Cell-free Tumor DNA Detection in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Cell-free Tumor DNA Detection Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Cell-free Tumor DNA Detection Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Cell-free Tumor DNA Detection Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Cell-free Tumor DNA Detection Revenue by Type (2017-2022) & (USD Million)
Table 27. World Cell-free Tumor DNA Detection Revenue by Type (2023-2028) & (USD Million)
Table 28. World Cell-free Tumor DNA Detection Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Cell-free Tumor DNA Detection Revenue by Application (2017-2022) & (USD Million)
Table 30. World Cell-free Tumor DNA Detection Revenue by Application (2023-2028) & (USD Million)
Table 31. Biocept Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Biocept Inc. Major Business
Table 33. Biocept Inc. Cell-free Tumor DNA Detection Product and Services
Table 34. Biocept Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Biocept Inc. Recent Developments/Updates
Table 36. Biocept Inc. Competitive Strengths & Weaknesses
Table 37. Bio-Rad Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 38. Bio-Rad Laboratories Inc. Major Business
Table 39. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product and Services
Table 40. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Bio-Rad Laboratories Inc. Recent Developments/Updates
Table 42. Bio-Rad Laboratories Inc. Competitive Strengths & Weaknesses
Table 43. Fluxion Biosciences Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Fluxion Biosciences Inc. Major Business
Table 45. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product and Services
Table 46. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Fluxion Biosciences Inc. Recent Developments/Updates
Table 48. Fluxion Biosciences Inc. Competitive Strengths & Weaknesses
Table 49. F. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table 50. F. Hoffmann-La Roche AG Major Business
Table 51. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product and Services
Table 52. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. F. Hoffmann-La Roche AG Recent Developments/Updates
Table 54. F. Hoffmann-La Roche AG Competitive Strengths & Weaknesses
Table 55. Sysmex Europe SE Basic Information, Manufacturing Base and Competitors
Table 56. Sysmex Europe SE Major Business
Table 57. Sysmex Europe SE Cell-free Tumor DNA Detection Product and Services
Table 58. Sysmex Europe SE Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Sysmex Europe SE Recent Developments/Updates
Table 60. Sysmex Europe SE Competitive Strengths & Weaknesses
Table 61. Qiagen Basic Information, Manufacturing Base and Competitors
Table 62. Qiagen Major Business
Table 63. Qiagen Cell-free Tumor DNA Detection Product and Services
Table 64. Qiagen Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Qiagen Recent Developments/Updates
Table 66. Qiagen Competitive Strengths & Weaknesses
Table 67. NeoGenomics Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 68. NeoGenomics Laboratories Inc. Major Business
Table 69. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product and Services
Table 70. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. NeoGenomics Laboratories Inc. Recent Developments/Updates
Table 72. NeoGenomics Laboratories Inc. Competitive Strengths & Weaknesses
Table 73. Menarini Silicon Biosystems Basic Information, Manufacturing Base and Competitors
Table 74. Menarini Silicon Biosystems Major Business
Table 75. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product and Services
Table 76. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Menarini Silicon Biosystems Recent Developments/Updates
Table 78. Menarini Silicon Biosystems Competitive Strengths & Weaknesses
Table 79. Illumina Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Illumina Inc. Major Business
Table 81. Illumina Inc. Cell-free Tumor DNA Detection Product and Services
Table 82. Illumina Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Illumina Inc. Recent Developments/Updates
Table 84. Illumina Inc. Competitive Strengths & Weaknesses
Table 85. Guardant Health Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Guardant Health Inc. Major Business
Table 87. Guardant Health Inc. Cell-free Tumor DNA Detection Product and Services
Table 88. Guardant Health Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Guardant Health Inc. Recent Developments/Updates
Table 90. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 91. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Major Business
Table 92. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product and Services
Table 93. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 94. Cell-free Tumor DNA Detection Raw Material
Table 95. Key Manufacturers of Cell-free Tumor DNA Detection Raw Materials
Table 96. Cell-free Tumor DNA Detection Typical Distributors
Table 97. Cell-free Tumor DNA Detection Typical Customers
LIST OF FIGURES
Figure 1. Cell-free Tumor DNA Detection Picture
Figure 2. World Cell-free Tumor DNA Detection Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Cell-free Tumor DNA Detection Total Market Size (2017-2028) & (USD Million)
Figure 4. World Cell-free Tumor DNA Detection Market Size Market Share by Region (2017-2028)
Figure 5. United States Cell-free Tumor DNA Detection Market Size (2017-2028) & (USD Million)
Figure 6. China Cell-free Tumor DNA Detection Market Size (2017-2028) & (USD Million)
Figure 7. Europe Cell-free Tumor DNA Detection Market Size (2017-2028) & (USD Million)
Figure 8. Japan Cell-free Tumor DNA Detection Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Cell-free Tumor DNA Detection Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Cell-free Tumor DNA Detection Market Size (2017-2028) & (USD Million)
Figure 11. India Cell-free Tumor DNA Detection Market Size (2017-2028) & (USD Million)
Figure 12. Cell-free Tumor DNA Detection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Cell-free Tumor DNA Detection by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Cell-free Tumor DNA Detection Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Cell-free Tumor DNA Detection Markets in 2021
Figure 17. United States VS China: Cell-free Tumor DNA Detection Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Cell-free Tumor DNA Detection Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Cell-free Tumor DNA Detection Market Size Market Share by Type in 2021
Figure 20. Droplet Digital Polymerase Chain Reaction
Figure 21. Tagged-Amplicon Deep Sequencing
Figure 22. Others
Figure 23. World Cell-free Tumor DNA Detection Market Size Market Share by Type (2017-2028)
Figure 24. World Cell-free Tumor DNA Detection Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 25. World Cell-free Tumor DNA Detection Market Size Market Share by Application in 2021
Figure 26. Breast Cancer
Figure 27. Stomach Cancer
Figure 28. Liver Cancer
Figure 29. Other
Figure 30. World Cell-free Tumor DNA Detection Market Size Market Share by Application (2017-2028)
Figure 31. Manufacturing Cost Structure Analysis of Cell-free Tumor DNA Detection in 2021
Figure 32. Manufacturing Process Analysis of Cell-free Tumor DNA Detection
Figure 33. Cell-free Tumor DNA Detection Industrial Chain
Figure 34. Distribution Channel Breakdown for Cell-free Tumor DNA Detection Shipments (%): 2017-2028
Figure 35. Direct Channel Pros & Cons
Figure 36. Indirect Channel Pros & Cons
Figure 37. Methodology
Figure 38. Research Process and Data Source
Figure 1. Cell-free Tumor DNA Detection Picture
Figure 2. World Cell-free Tumor DNA Detection Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Cell-free Tumor DNA Detection Total Market Size (2017-2028) & (USD Million)
Figure 4. World Cell-free Tumor DNA Detection Market Size Market Share by Region (2017-2028)
Figure 5. United States Cell-free Tumor DNA Detection Market Size (2017-2028) & (USD Million)
Figure 6. China Cell-free Tumor DNA Detection Market Size (2017-2028) & (USD Million)
Figure 7. Europe Cell-free Tumor DNA Detection Market Size (2017-2028) & (USD Million)
Figure 8. Japan Cell-free Tumor DNA Detection Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Cell-free Tumor DNA Detection Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Cell-free Tumor DNA Detection Market Size (2017-2028) & (USD Million)
Figure 11. India Cell-free Tumor DNA Detection Market Size (2017-2028) & (USD Million)
Figure 12. Cell-free Tumor DNA Detection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Cell-free Tumor DNA Detection by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Cell-free Tumor DNA Detection Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Cell-free Tumor DNA Detection Markets in 2021
Figure 17. United States VS China: Cell-free Tumor DNA Detection Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Cell-free Tumor DNA Detection Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Cell-free Tumor DNA Detection Market Size Market Share by Type in 2021
Figure 20. Droplet Digital Polymerase Chain Reaction
Figure 21. Tagged-Amplicon Deep Sequencing
Figure 22. Others
Figure 23. World Cell-free Tumor DNA Detection Market Size Market Share by Type (2017-2028)
Figure 24. World Cell-free Tumor DNA Detection Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 25. World Cell-free Tumor DNA Detection Market Size Market Share by Application in 2021
Figure 26. Breast Cancer
Figure 27. Stomach Cancer
Figure 28. Liver Cancer
Figure 29. Other
Figure 30. World Cell-free Tumor DNA Detection Market Size Market Share by Application (2017-2028)
Figure 31. Manufacturing Cost Structure Analysis of Cell-free Tumor DNA Detection in 2021
Figure 32. Manufacturing Process Analysis of Cell-free Tumor DNA Detection
Figure 33. Cell-free Tumor DNA Detection Industrial Chain
Figure 34. Distribution Channel Breakdown for Cell-free Tumor DNA Detection Shipments (%): 2017-2028
Figure 35. Direct Channel Pros & Cons
Figure 36. Indirect Channel Pros & Cons
Figure 37. Methodology
Figure 38. Research Process and Data Source
